{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:21:13Z","timestamp":1791483673666,"version":"4.3.4"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00210-024-03385-0","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T07:02:06Z","timestamp":1725346926000},"page":"1057-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mpox treatment evolution: past milestones, present advances, and future directions"],"prefix":"10.1007","volume":"398","author":[{"given":"Alagammai","family":"Ganesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumalai","family":"Arunagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganandhini","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Ravi","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathrii","family":"SK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhiya","family":"Elumalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanaka Parvathi","family":"Kannaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanth Kumar","family":"Chanduluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"3385_CR1","unstructured":"2022-24 Mpox (monkeypox) outbreak: global trends (2024). Available at: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/ (Accessed: 6 August 2024)"},{"key":"3385_CR2","unstructured":"2022-24 Mpox outbreak: global trends (2024). Available at: https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/ (Accessed: 6 August 2024)"},{"key":"3385_CR3","unstructured":"A clinical study investigating the safety and immune responses after immunization with investigational monkeypox vaccines (2024). Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05988203 (Accessed: 13 May 2024)"},{"issue":"8","key":"3385_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H et al (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22(8):1153\u20131162. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"3385_CR5","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/v14091960","volume":"14","author":"SF Ahmed","year":"2022","unstructured":"Ahmed SF et al (2022) Vaccinia-virus-based vaccines are expected to elicit highly cross-reactive immunity to the 2022 monkeypox virus. Viruses 14(9):1960. https:\/\/doi.org\/10.3390\/v14091960","journal-title":"Viruses"},{"issue":"3","key":"3385_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1124\/mol.63.3.678","volume":"63","author":"KA Aldern","year":"2003","unstructured":"Aldern KA et al (2003) Increased antiviral activity of 1- o -hexadecyloxypropyl-[2- 14 C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism. Mol Pharmacol 63(3):678\u2013681. https:\/\/doi.org\/10.1124\/mol.63.3.678","journal-title":"Mol Pharmacol"},{"key":"3385_CR7","unstructured":"Assessment of safety profile of MVA-BN vaccine in the PALM-007 study in DRC (2023)"},{"key":"3385_CR8","unstructured":"Assessment of the efficacy and safety of tecovirimat in patients with monkeypox virus disease (UNITY) (2023). Available at: https:\/\/clinicaltrials.gov\/study\/NCT05597735 (Accessed: 24 November 2023)"},{"key":"3385_CR9","doi-asserted-by":"publisher","unstructured":"Beer, E.M. and Rao, V.B. (2019) \u2018A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLOS Neglected Tropical Diseases. Edited by M.R. Holbrook, 13(10), e0007791. https:\/\/doi.org\/10.1371\/journal.pntd.0007791","DOI":"10.1371\/journal.pntd.0007791"},{"issue":"3","key":"3385_CR10","doi-asserted-by":"publisher","first-page":"e28652","DOI":"10.1002\/jmv.28652","volume":"95","author":"D Bojkova","year":"2023","unstructured":"Bojkova D et al (2023) \u2018Repurposing of the antibiotic nitroxoline for the treatment of mpox. J Med Virol 95(3):e28652. https:\/\/doi.org\/10.1002\/jmv.28652","journal-title":"J Med Virol"},{"issue":"2","key":"3385_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13337-023-00826-x","volume":"34","author":"S Boora","year":"2023","unstructured":"Boora S et al (2023) Monkeypox virus is nature\u2019s wake-up call: a bird\u2019s-eye view. VirusDisease 34(2):191\u2013203. https:\/\/doi.org\/10.1007\/s13337-023-00826-x","journal-title":"VirusDisease"},{"issue":"8","key":"3385_CR12","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.3390\/jcm13082234","volume":"13","author":"F Branda","year":"2024","unstructured":"Branda F et al (2024) Mpox: an overview of pathogenesis, diagnosis, and public health implications. J Clin Med 13(8):2234. https:\/\/doi.org\/10.3390\/jcm13082234","journal-title":"J Clin Med"},{"key":"3385_CR13","unstructured":"Break-through infection following Mpox vaccination (REMAIN). (2022)"},{"issue":"7","key":"3385_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41587-020-0513-4","volume":"38","author":"J Broughton","year":"2020","unstructured":"Broughton J et al (2020) CRISPR\u2013Cas12-based detection of SARS-CoV-2. Nat Biotechnol 38(7):870\u2013874. https:\/\/doi.org\/10.1038\/s41587-020-0513-4","journal-title":"Nat Biotechnol"},{"issue":"10","key":"3385_CR15","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/life13101969","volume":"13","author":"G Bruno","year":"2023","unstructured":"Bruno G, Buccoliero GB (2023) Antivirals against monkeypox (Mpox) in humans: an updated narrative review. Life 13(10):1969. https:\/\/doi.org\/10.3390\/life13101969","journal-title":"Life"},{"issue":"9","key":"3385_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1517\/13543784.13.9.1207","volume":"13","author":"RW Buckheit","year":"2004","unstructured":"Buckheit RW (2004) The 17th international conference on antiviral research. Expert Opin Invest Drugs 13(9):1207\u20131212. https:\/\/doi.org\/10.1517\/13543784.13.9.1207","journal-title":"Expert Opin Invest Drugs"},{"key":"3385_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jcis.2023.12.188","volume":"660","author":"M Chandran","year":"2024","unstructured":"Chandran M et al (2024) Fabrication of label-free immunoprobe for monkeypox A29 detection using one-step electrodeposited molybdenum oxide-graphene quantum rods. J Colloid Interf Sci 660:412\u2013422. https:\/\/doi.org\/10.1016\/j.jcis.2023.12.188","journal-title":"J Colloid Interf Sci"},{"key":"3385_CR18","doi-asserted-by":"publisher","unstructured":"Chen Y et al. (2011) Comparison of the safety and pharmacokinetics of ST-246\u00ae after IV infusion or oral administration in mice, rabbits and monkeys. PLoS ONE. Edited by R. Jhaveri, 6(8), e23237. https:\/\/doi.org\/10.1371\/journal.pone.0023237","DOI":"10.1371\/journal.pone.0023237"},{"key":"3385_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","volume":"143","author":"G Chittick","year":"2017","unstructured":"Chittick G et al (2017) Short-term clinical safety profile of brincidofovir: a favorable benefit\u2013risk proposition in the treatment of smallpox. Antiviral Res 143:269\u2013277. https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.009","journal-title":"Antiviral Res"},{"issue":"3","key":"3385_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","volume":"59","author":"SL Ciesla","year":"2003","unstructured":"Ciesla SL et al (2003) Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. Antiviral Res 59(3):163\u2013171. https:\/\/doi.org\/10.1016\/S0166-3542(03)00110-4","journal-title":"Antiviral Res"},{"issue":"3","key":"3385_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0090-9556(25)07349-0","volume":"24","author":"KC Cundy","year":"1996","unstructured":"Cundy KC, Li ZH, Lee WA (1996) \u2018Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug metabolism and disposition biological fate of chemicals 24(3):315\u201321","journal-title":"Drug metabolism and disposition biological fate of chemicals"},{"key":"3385_CR22","doi-asserted-by":"publisher","unstructured":"de la Calle-Prieto F et al. (2022) Tratamiento y prevenci\u00f3n de la viruela del mono. Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. https:\/\/doi.org\/10.1016\/j.eimc.2022.08.001","DOI":"10.1016\/j.eimc.2022.08.001"},{"issue":"13","key":"3385_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.2022.15336","volume":"328","author":"AN Desai","year":"2022","unstructured":"Desai AN et al (2022) Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA 328(13):1348. https:\/\/doi.org\/10.1001\/jama.2022.15336","journal-title":"JAMA"},{"issue":"6","key":"3385_CR24","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1097\/MPH.0000000000001227","volume":"40","author":"CJ Detweiler","year":"2018","unstructured":"Detweiler CJ et al (2018) Brincidofovir (CMX001) Toxicity associated with epithelial apoptosis and crypt drop out in a hematopoietic cell transplant patient: challenges in distinguishing drug toxicity from GVHD. J Pediatr Hematol\/Oncol 40(6):e364\u2013e368. https:\/\/doi.org\/10.1097\/MPH.0000000000001227","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"1","key":"3385_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/AAC.01601-13","volume":"58","author":"S Duraffour","year":"2014","unstructured":"Duraffour S et al (2014) KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo. Antimicrob Agents Chemother 58(1):27\u201337. https:\/\/doi.org\/10.1128\/AAC.01601-13","journal-title":"Antimicrob Agents Chemother"},{"key":"3385_CR26","doi-asserted-by":"crossref","unstructured":"Duraffour S et al (2007) Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Antiviral therapy, 12(8), 1205\u201316. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18240860","DOI":"10.1177\/135965350701200802"},{"issue":"5","key":"3385_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jcb.30397","volume":"124","author":"M Dutt","year":"2023","unstructured":"Dutt M et al (2023) Drug repurposing for Mpox: discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach. J Cell Biochem 124(5):701\u2013715. https:\/\/doi.org\/10.1002\/jcb.30397","journal-title":"J Cell Biochem"},{"issue":"5","key":"3385_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/eid2505.190076","volume":"25","author":"N Erez","year":"2019","unstructured":"Erez N et al (2019) Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis 25(5):980\u2013983. https:\/\/doi.org\/10.3201\/eid2505.190076","journal-title":"Emerg Infect Dis"},{"key":"3385_CR29","unstructured":"European trial into Mpox infection (EPOXI)(2023)"},{"issue":"5","key":"3385_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/17460441.2023.2199980","volume":"18","author":"AA Ezat","year":"2023","unstructured":"Ezat AA et al (2023) The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Exp Opinion Drug Discover 18(5):551\u2013561. https:\/\/doi.org\/10.1080\/17460441.2023.2199980","journal-title":"Exp Opinion Drug Discover"},{"issue":"2","key":"3385_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s15010-022-01949-x","volume":"51","author":"C Fabrizio","year":"2023","unstructured":"Fabrizio C et al (2023) Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome. Infection 51(2):519\u2013522. https:\/\/doi.org\/10.1007\/s15010-022-01949-x","journal-title":"Infection"},{"key":"3385_CR32","unstructured":"FDA (2024) JYNNEOS vaccine"},{"issue":"39","key":"3385_CR33","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1016\/j.vaccine.2015.06.075","volume":"33","author":"SE Frey","year":"2015","unstructured":"Frey SE et al (2015) Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects. Vaccine 33(39):5225\u20135234. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.075","journal-title":"Vaccine"},{"issue":"716","key":"3385_CR34","doi-asserted-by":"publisher","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn AW et al (2023) An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci Trans Med 15(716):eadg3540. https:\/\/doi.org\/10.1126\/scitranslmed.adg3540","journal-title":"Sci Trans Med"},{"issue":"6336","key":"3385_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1126\/science.aam9321","volume":"356","author":"JS Gootenberg","year":"2017","unstructured":"Gootenberg JS et al (2017) Nucleic acid detection with CRISPR-Cas13a\/C2c2. Science 356(6336):438\u2013442. https:\/\/doi.org\/10.1126\/science.aam9321","journal-title":"Science"},{"key":"3385_CR36","doi-asserted-by":"publisher","unstructured":"Grayson ML et al. (eds) (2017) Kucers\u2019 the use of antibiotics. CRC Press. https:\/\/doi.org\/10.1201\/9781498747967","DOI":"10.1201\/9781498747967"},{"issue":"4","key":"3385_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40257-023-00778-4","volume":"24","author":"AK Gupta","year":"2023","unstructured":"Gupta AK et al (2023) Differential diagnosis, prevention, and treatment of mpox (monkeypox): a review for dermatologists. Am J Clin Dermatol 24(4):541\u2013556. https:\/\/doi.org\/10.1007\/s40257-023-00778-4","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"3385_CR38","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1080\/22221751.2022.2132882","volume":"11","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM et al (2022) Comprehensive literature review of monkeypox. Emerg Microb Infect 11(1):2600\u20132631. https:\/\/doi.org\/10.1080\/22221751.2022.2132882","journal-title":"Emerg Microb Infect"},{"issue":"12","key":"3385_CR39","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ajt.2023.07.016","volume":"23","author":"E Higgins","year":"2023","unstructured":"Higgins E et al (2023) Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: a multicenter case series and literature review. Am J Transplant 23(12):1972\u20131979. https:\/\/doi.org\/10.1016\/j.ajt.2023.07.016","journal-title":"Am J Transplant"},{"issue":"2","key":"3385_CR40","doi-asserted-by":"publisher","first-page":"A84","DOI":"10.1016\/j.antiviral.2009.01.005","volume":"82","author":"KY Hostetler","year":"2009","unstructured":"Hostetler KY (2009) Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antiviral Res 82(2):A84\u2013A98. https:\/\/doi.org\/10.1016\/j.antiviral.2009.01.005","journal-title":"Antiviral Res"},{"issue":"1","key":"3385_CR41","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou F et al (2023) mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat Commun 14(1):5925. https:\/\/doi.org\/10.1038\/s41467-023-41628-5","journal-title":"Nat Commun"},{"issue":"1","key":"3385_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","volume":"7","author":"Y Huang","year":"2022","unstructured":"Huang Y, Mu L, Wang W (2022) Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther 7(1):373. https:\/\/doi.org\/10.1038\/s41392-022-01215-4","journal-title":"Signal Transduct Target Ther"},{"key":"3385_CR43","doi-asserted-by":"publisher","unstructured":"Hutson CL et al. (2021) Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere. Edited by J. Schoggins, 6(1). https:\/\/doi.org\/10.1128\/mSphere.00927-20","DOI":"10.1128\/mSphere.00927-20"},{"issue":"6","key":"3385_CR44","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1128\/AAC.01689-09","volume":"54","author":"R Jordan","year":"2010","unstructured":"Jordan R et al (2010) Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects. Antimicrob Agents Chemother 54(6):2560\u20132566. https:\/\/doi.org\/10.1128\/AAC.01689-09","journal-title":"Antimicrob Agents Chemother"},{"key":"3385_CR45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26531","author":"J Kaler","year":"2022","unstructured":"Kaler J et al (2022) Monkeypox: A comprehensive review of transmission pathogenesis and manifestation. Cureus. https:\/\/doi.org\/10.7759\/cureus.26531","journal-title":"Cureus"},{"issue":"4","key":"3385_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","volume":"16","author":"A Karagoz","year":"2023","unstructured":"Karagoz A et al (2023) Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Pub Health 16(4):531\u2013541. https:\/\/doi.org\/10.1016\/j.jiph.2023.02.003","journal-title":"J Infect Pub Health"},{"issue":"24","key":"3385_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/phrev.phrev_2_18","volume":"12","author":"S Kaushik","year":"2018","unstructured":"Kaushik S et al (2018) Antiviral and therapeutic uses of medicinal plants and their derivatives against dengue viruses. Pharmacognosy Rev 12(24):177. https:\/\/doi.org\/10.4103\/phrev.phrev_2_18","journal-title":"Pharmacognosy Rev"},{"issue":"1","key":"3385_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12906-021-03402-2","volume":"21","author":"S Kaushik","year":"2021","unstructured":"Kaushik S et al (2021) Anti-dengue activity of super critical extract and isolated oleanolic acid of Leucas cephalotes using in vitro and in silico approach. BMC Complement Med Ther 21(1):227. https:\/\/doi.org\/10.1186\/s12906-021-03402-2","journal-title":"BMC Complement Med Ther"},{"key":"3385_CR49","doi-asserted-by":"publisher","unstructured":"Kharwar, R. et al. (2024) \u2018A computational approach to identify natural putative inhibitors to combat monkeypox. In: Nanotechnology and In Silico Tools. Elsevier, 285\u2013308. https:\/\/doi.org\/10.1016\/B978-0-443-15457-7.00025-3","DOI":"10.1016\/B978-0-443-15457-7.00025-3"},{"issue":"1","key":"3385_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/2211738507666191024162042","volume":"8","author":"M Kheirollahpour","year":"2020","unstructured":"Kheirollahpour M et al (2020) Nanoparticles and vaccine development. Pharm Nanotechnol 8(1):6\u201321. https:\/\/doi.org\/10.2174\/2211738507666191024162042","journal-title":"Pharm Nanotechnol"},{"key":"3385_CR51","unstructured":"Lesion transmission (23-10-2023). Available at: https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/clinical-recognition.html#:~:text=The evolution of lesions progresses,typically lasts 2-4 weeks. (Accessed: 23 October 2023)"},{"issue":"3","key":"3385_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcv.2006.03.012","volume":"36","author":"Y Li","year":"2006","unstructured":"Li Y et al (2006) Detection of monkeypox virus with real-time PCR assays. J Clin Virol 36(3):194\u2013203. https:\/\/doi.org\/10.1016\/j.jcv.2006.03.012","journal-title":"J Clin Virol"},{"issue":"1","key":"3385_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jviromet.2010.07.012","volume":"169","author":"Y Li","year":"2010","unstructured":"Li Y et al (2010) Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virologic Methods 169(1):223\u2013227. https:\/\/doi.org\/10.1016\/j.jviromet.2010.07.012","journal-title":"J Virologic Methods"},{"issue":"1","key":"3385_CR54","doi-asserted-by":"publisher","first-page":"e28429","DOI":"10.1002\/jmv.28429","volume":"95","author":"CK Lim","year":"2023","unstructured":"Lim CK et al (2023) Mpox diagnostics: review of current and emerging technologies. J Med Virol 95(1):e28429. https:\/\/doi.org\/10.1002\/jmv.28429","journal-title":"J Med Virol"},{"issue":"2","key":"3385_CR55","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/S1473-3099(22)00722-8","volume":"23","author":"DA Lindholm","year":"2023","unstructured":"Lindholm DA, Kalil AC (2023) D\u00e9j\u00e0 vu all over again? Monkeypox and the urgent need for randomised controlled trials. Lancet Infect Dis 23(2):e56\u2013e58. https:\/\/doi.org\/10.1016\/S1473-3099(22)00722-8","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"3385_CR56","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","volume":"49","author":"WC Magee","year":"2005","unstructured":"Magee WC, Hostetler KY, Evans DH (2005) Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicro Agents Chemother 49(8):3153\u20133162. https:\/\/doi.org\/10.1128\/AAC.49.8.3153-3162.2005","journal-title":"Antimicro Agents Chemother"},{"issue":"3","key":"3385_CR57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/vaccines11030500","volume":"11","author":"S Malik","year":"2023","unstructured":"Malik S et al (2023) Recent developments in Mpox prevention and treatment options. Vaccines 11(3):500. https:\/\/doi.org\/10.3390\/vaccines11030500","journal-title":"Vaccines"},{"issue":"8","key":"3385_CR58","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/ofid\/ofac377","volume":"9","author":"WR Matias","year":"2022","unstructured":"Matias WR et al (2022) Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open Forum Infect Dis 9(8):377. https:\/\/doi.org\/10.1093\/ofid\/ofac377","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"3385_CR59","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/infdis\/jiaa559","volume":"225","author":"MR Mauldin","year":"2022","unstructured":"Mauldin MR et al (2022) Exportation of monkeypox virus from the African continent. J Infect Dis 225(8):1367\u20131376. https:\/\/doi.org\/10.1093\/infdis\/jiaa559","journal-title":"J Infect Dis"},{"issue":"5","key":"3385_CR60","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1099\/jgv.0.000422","volume":"97","author":"OY Mazurkov","year":"2016","unstructured":"Mazurkov OY et al (2016) New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol 97(5):1229\u20131239. https:\/\/doi.org\/10.1099\/jgv.0.000422","journal-title":"J Gen Virol"},{"issue":"6","key":"3385_CR61","doi-asserted-by":"publisher","first-page":"e28868","DOI":"10.1002\/jmv.28868","volume":"95","author":"V Mazzotta","year":"2023","unstructured":"Mazzotta V et al (2023) Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox. J Med Virol 95(6):e28868. https:\/\/doi.org\/10.1002\/jmv.28868","journal-title":"J Med Virol"},{"issue":"11","key":"3385_CR62","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/vaccines10111971","volume":"10","author":"SA Meo","year":"2022","unstructured":"Meo SA et al (2022) Comparison of biological, pharmacological characteristics, indications, contraindications and adverse effects of JYNNEOS and ACAM2000 Monkeypox Vaccines. Vaccines 10(11):1971. https:\/\/doi.org\/10.3390\/vaccines10111971","journal-title":"Vaccines"},{"issue":"10380","key":"3385_CR63","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O et al (2023) Mpox in people with advanced HIV infection: a global case series. The Lancet 401(10380):939\u2013949. https:\/\/doi.org\/10.1016\/S0140-6736(23)00273-8","journal-title":"The Lancet"},{"issue":"24","key":"3385_CR64","doi-asserted-by":"publisher","first-page":"2200448","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","volume":"27","author":"F Miura","year":"2022","unstructured":"Miura F et al (2022) Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Eurosurveillance 27(24):2200448. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.24.2200448","journal-title":"Eurosurveillance"},{"issue":"2","key":"3385_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/vaccines11020428","volume":"11","author":"NA Mohamed","year":"2023","unstructured":"Mohamed NA et al (2023) Nanomedicine as a potential tool against monkeypox. Vaccines 11(2):428. https:\/\/doi.org\/10.3390\/vaccines11020428","journal-title":"Vaccines"},{"key":"3385_CR66","doi-asserted-by":"publisher","unstructured":"Mohamed A (2020) Iron-based nanoparticles, an accurate and powerful sniper targeting SARS- Cov-2. Adv Cardiovasc Res, 3(3). https:\/\/doi.org\/10.32474\/ACR.2020.03.000162","DOI":"10.32474\/ACR.2020.03.000162"},{"key":"3385_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102636","volume":"56","author":"S Mohanto","year":"2023","unstructured":"Mohanto S et al (2023) Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms. Travel Med Infect Dis 56:102636. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102636","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"3385_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jinf.2022.11.001","volume":"86","author":"A Mondi","year":"2023","unstructured":"Mondi A et al (2023) Clinical experience with use of oral tecovirimat or intravenous cidofovir for the treatment of monkeypox in an Italian reference hospital. J Infect 86(1):66\u2013117. https:\/\/doi.org\/10.1016\/j.jinf.2022.11.001","journal-title":"J Infect"},{"key":"3385_CR69","unstructured":"Moore, M.J., Rathish, B. and Zahra, F. (2024) Mpox (monkeypox), StatPearls. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4349404"},{"key":"3385_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102417","volume":"49","author":"D Moschese","year":"2022","unstructured":"Moschese D et al (2022) Hospitalisation for monkeypox in Milan, Italy. Travel Med Infect Dis 49:102417. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102417","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"3385_CR71","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12985-024-02397-9","volume":"21","author":"F Movahed","year":"2024","unstructured":"Movahed F et al (2024) The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV). Virol J 21(1):124. https:\/\/doi.org\/10.1186\/s12985-024-02397-9","journal-title":"Virol J"},{"key":"3385_CR72","unstructured":"Mpox (monkeypox)- Democratic Republic of the Congo. Available at: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON493 (Accessed: 6 August 2024)"},{"key":"3385_CR73","unstructured":"Mpox treatment information for healthcare professionals\u00a0(2024). Available at: https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/treatment.html"},{"key":"3385_CR74","doi-asserted-by":"publisher","unstructured":"Nalca A, Zumbrun EE (2010) ACAM2000™: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des Devel Ther, 71. https:\/\/doi.org\/10.2147\/DDDT.S3687","DOI":"10.2147\/DDDT.S3687"},{"key":"3385_CR75","unstructured":"NCT05740982 (2023) \u2018A phase 2 randomized multisite trial to inform public health strategies involving the use of MVA-BN vaccine for Mpox\u2019, https:\/\/clinicaltrials.gov\/show\/NCT05740982 Available at: https:\/\/www.cochranelibrary.com\/central\/doi\/10.1002\/central\/CN-02531117\/full"},{"key":"3385_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2023.106960","volume":"245","author":"J Nyame","year":"2023","unstructured":"Nyame J et al (2023) Challenges in the treatment and prevention of monkeypox infection; a comprehensive review. Acta Tropica 245:106960. https:\/\/doi.org\/10.1016\/j.actatropica.2023.106960","journal-title":"Acta Tropica"},{"issue":"12","key":"3385_CR77","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cmi.2023.07.011","volume":"29","author":"T Okwor","year":"2023","unstructured":"Okwor T et al (2023) A contemporary review of clade-specific virological differences in monkeypox viruses. Clin Microbiol Infect 29(12):1502\u20131507. https:\/\/doi.org\/10.1016\/j.cmi.2023.07.011","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3385_CR78","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N et al (2018) mRNA vaccines \u2014 a new era in vaccinology. Nat Rev Drug Discover 17(4):261\u2013279. https:\/\/doi.org\/10.1038\/nrd.2017.243","journal-title":"Nat Rev Drug Discover"},{"issue":"1","key":"3385_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2007.08.003","volume":"77","author":"S Parker","year":"2008","unstructured":"Parker S et al (2008) Efficacy of therapeutic intervention with an oral ether\u2013lipid analogue of cidofovir (CMX001) in a lethal mousepox model. Antiviral Res 77(1):39\u201349. https:\/\/doi.org\/10.1016\/j.antiviral.2007.08.003","journal-title":"Antiviral Res"},{"issue":"1","key":"3385_CR80","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/life13010249","volume":"13","author":"M Patel","year":"2023","unstructured":"Patel M et al (2023) Current insights into diagnosis, prevention strategies, treatment, therapeutic targets, and challenges of monkeypox (Mpox) infections in human populations. Life 13(1):249. https:\/\/doi.org\/10.3390\/life13010249","journal-title":"Life"},{"issue":"4","key":"3385_CR81","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","volume":"33","author":"E Petersen","year":"2019","unstructured":"Petersen E et al (2019) Human monkeypox. Infect Dis Clin North Am 33(4):1027\u20131043. https:\/\/doi.org\/10.1016\/j.idc.2019.03.001","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"3385_CR82","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1021\/jm049147h","volume":"48","author":"MC Pirrung","year":"2005","unstructured":"Pirrung MC et al (2005) Combinatorial optimization of isatin-\u03b2-thiosemicarbazones as anti-poxvirus agents. J Med Chem 48(8):3045\u20133050. https:\/\/doi.org\/10.1021\/jm049147h","journal-title":"J Med Chem"},{"issue":"12","key":"3385_CR83","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","volume":"22","author":"GA Poland","year":"2022","unstructured":"Poland GA, Kennedy RB, Tosh PK (2022) Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis 22(12):e349\u2013e358. https:\/\/doi.org\/10.1016\/S1473-3099(22)00574-6","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"3385_CR84","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/AAC.47.10.3275-3280.2003","volume":"47","author":"DC Quenelle","year":"2003","unstructured":"Quenelle DC, Collins DJ, Kern ER (2003) Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice. Antimicrob Agents Chemother 47(10):3275\u20133280. https:\/\/doi.org\/10.1128\/AAC.47.10.3275-3280.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3385_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.antiviral.2006.02.010","volume":"71","author":"DC Quenelle","year":"2006","unstructured":"Quenelle DC, Keith KA, Kern ER (2006) In vitro and in vivo evaluation of isatin-\u03b2-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res 71(1):24\u201330. https:\/\/doi.org\/10.1016\/j.antiviral.2006.02.010","journal-title":"Antiviral Res"},{"issue":"11","key":"3385_CR86","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1128\/AAC.00762-07","volume":"51","author":"DC Quenelle","year":"2007","unstructured":"Quenelle DC et al (2007) Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother 51(11):4118\u20134124. https:\/\/doi.org\/10.1128\/AAC.00762-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3385_CR87","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1128\/AAC.00184-07","volume":"51","author":"DC Quenelle","year":"2007","unstructured":"Quenelle DC et al (2007) Effect of oral treatment with hexadecyloxypropyl-[( S )-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [( S )-HPMPA] or octadecyloxyethyl-( S )-HPMPA on cowpox or vaccinia virus infections in mice. Antimicrob Agents Chemother 51(11):3940\u20133947. https:\/\/doi.org\/10.1128\/AAC.00184-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3385_CR88","doi-asserted-by":"publisher","first-page":"e28825","DOI":"10.1002\/jmv.28825","volume":"95","author":"AR Raccagni","year":"2023","unstructured":"Raccagni AR et al (2023) Rapid improvement of severe Mpox lesions with oral tecovirimat. J Med Virol 95(6):e28825. https:\/\/doi.org\/10.1002\/jmv.28825","journal-title":"J Med Virol"},{"issue":"4","key":"3385_CR89","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00210-023-02769-y","volume":"397","author":"I Rani","year":"2024","unstructured":"Rani I et al (2024) Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397(4):2055\u20132065. https:\/\/doi.org\/10.1007\/s00210-023-02769-y","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"9","key":"3385_CR90","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG et al (2022) Prevention and treatment of monkeypox. Drugs 82(9):957\u2013963. https:\/\/doi.org\/10.1007\/s40265-022-01742-y","journal-title":"Drugs"},{"key":"3385_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106156","volume":"180","author":"MJ Saadh","year":"2023","unstructured":"Saadh MJ et al (2023) Progress and prospects on vaccine development against monkeypox infection. Microbial Pathogenesis 180:106156. https:\/\/doi.org\/10.1016\/j.micpath.2023.106156","journal-title":"Microbial Pathogenesis"},{"issue":"1","key":"3385_CR92","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang Y et al (2023) Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct Target Ther 8(1):172. https:\/\/doi.org\/10.1038\/s41392-023-01432-5","journal-title":"Signal Transduct Target Ther"},{"key":"3385_CR93","doi-asserted-by":"publisher","first-page":"1149909","DOI":"10.3389\/fphar.2023.1149909","volume":"14","author":"MA Shamim","year":"2023","unstructured":"Shamim MA et al (2023) \u2018Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis. Front Pharmacol 14:1149909. https:\/\/doi.org\/10.3389\/fphar.2023.1149909","journal-title":"Front Pharmacol"},{"issue":"2","key":"3385_CR94","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00253-018-9488-1","volume":"103","author":"V Sharma","year":"2019","unstructured":"Sharma V et al (2019) Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Appl Microbiol Biotechnol 103(2):881\u2013891. https:\/\/doi.org\/10.1007\/s00253-018-9488-1","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3385_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cid\/ciac622","volume":"76","author":"EA Siegrist","year":"2023","unstructured":"Siegrist EA, Sassine J (2023) Antivirals with activity against Mpox: a clinically oriented review. Clin Infect Dis 76(1):155\u2013164. https:\/\/doi.org\/10.1093\/cid\/ciac622","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3385_CR96","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s12098-022-04348-0","volume":"89","author":"T Singhal","year":"2022","unstructured":"Singhal T, Kabra SK, Lodha R (2022) Monkeypox: a review. Indian J Pediatr 89(10):955\u2013960. https:\/\/doi.org\/10.1007\/s12098-022-04348-0","journal-title":"Indian J Pediatr"},{"key":"3385_CR97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","volume":"6","author":"N Sklenovsk\u00e1","year":"2018","unstructured":"Sklenovsk\u00e1 N, Van Ranst M (2018) Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health 6:241. https:\/\/doi.org\/10.3389\/fpubh.2018.00241","journal-title":"Front Public Health"},{"key":"3385_CR98","doi-asserted-by":"publisher","unstructured":"\u2018Smallpox vaccine\u2019 (2016) In Meyler\u2019s side effects of drugs. Elsevier, 411\u2013417. https:\/\/doi.org\/10.1016\/B978-0-444-53717-1.01455-4","DOI":"10.1016\/B978-0-444-53717-1.01455-4"},{"key":"3385_CR99","unstructured":"Smallpox vaccine for Mpox post-exposure prophylaxis: a cluster RCT (SMART) (2023)"},{"issue":"2","key":"3385_CR100","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.antiviral.2007.06.005","volume":"76","author":"DF Smee","year":"2007","unstructured":"Smee DF et al (2007) Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. Antiviral Res 76(2):124\u2013129. https:\/\/doi.org\/10.1016\/j.antiviral.2007.06.005","journal-title":"Antiviral Res"},{"key":"3385_CR101","unstructured":"Study of tecovirimat for human MPXV (STOMP) (2022)"},{"issue":"6","key":"3385_CR102","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/idr14060087","volume":"14","author":"N Thakur","year":"2022","unstructured":"Thakur N (2022) MonkeyPox2022Tweets: a large-scale Twitter dataset on the 2022 monkeypox outbreak, findings from analysis of Tweets, and open research questions. Infect Dis Rep 14(6):855\u2013883. https:\/\/doi.org\/10.3390\/idr14060087","journal-title":"Infect Dis Rep"},{"issue":"8","key":"3385_CR103","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP et al (2022) Monkeypox virus infection in humans across 16 countries \u2014 April\u2013June 2022. New England J Med 387(8):679\u2013691. https:\/\/doi.org\/10.1056\/NEJMoa2207323","journal-title":"New England J Med"},{"issue":"2","key":"3385_CR104","doi-asserted-by":"publisher","first-page":"e167632","DOI":"10.1172\/JCI167632","volume":"133","author":"BK Titanji","year":"2023","unstructured":"Titanji BK, Marconi VC (2023) Vaxxing to elimination: smallpox vaccines as tools to fight mpox. J Clin Invest 133(2):e167632. https:\/\/doi.org\/10.1172\/JCI167632","journal-title":"J Clin Invest"},{"issue":"11","key":"3385_CR105","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3201\/eid2811.221215","volume":"28","author":"M Turner","year":"2022","unstructured":"Turner M et al (2022) Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak. Emerging Infect Dis 28(11):2336\u20132338. https:\/\/doi.org\/10.3201\/eid2811.221215","journal-title":"Emerging Infect Dis"},{"issue":"1","key":"3385_CR106","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.rceng.2022.09.002","volume":"223","author":"MA Vel\u00e1zquez-Cervantes","year":"2023","unstructured":"Vel\u00e1zquez-Cervantes MA, Ulloa-Aguilar JM, Le\u00f3n-Ju\u00e1rez M (2023) Mpox and pregnancy: a neglected disease and its impact on perinatal health. Revista Cl\u00ednica Espa\u00f1ola (English Edition) 223(1):32\u201339. https:\/\/doi.org\/10.1016\/j.rceng.2022.09.002","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"issue":"1","key":"3385_CR107","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/s41467-024-47518-8","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Ultrasensitive single-step CRISPR detection of monkeypox virus in minutes with a vest-pocket diagnostic device. Nat Commun 15(1):3279. https:\/\/doi.org\/10.1038\/s41467-024-47518-8","journal-title":"Nat Commun"},{"issue":"2","key":"3385_CR108","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1128\/JVI.00984-08","volume":"83","author":"H Wei","year":"2009","unstructured":"Wei H et al (2009) Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox. J Virol 83(2):1115\u20131125. https:\/\/doi.org\/10.1128\/JVI.00984-08","journal-title":"J Virol"},{"issue":"1","key":"3385_CR109","doi-asserted-by":"publisher","first-page":"28","DOI":"10.31646\/gbio.12","volume":"1","author":"J Yu","year":"2019","unstructured":"Yu J, Raj MS (2019) \u2018Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review. Glob Biosecur 1(1):28. https:\/\/doi.org\/10.31646\/gbio.12","journal-title":"Glob Biosecur"},{"issue":"1","key":"3385_CR110","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12274-022-4627-5","volume":"16","author":"M Zhang","year":"2023","unstructured":"Zhang M et al (2023) mRNA-based modalities for infectious disease management. Nano Res 16(1):672\u2013691. https:\/\/doi.org\/10.1007\/s12274-022-4627-5","journal-title":"Nano Res"},{"issue":"2","key":"3385_CR111","doi-asserted-by":"publisher","first-page":"28479","DOI":"10.1002\/jmv.28479","volume":"95","author":"J Zhou","year":"2023","unstructured":"Zhou J et al (2023) Rapid detection of monkeypox virus by multiple cross displacement amplification combined with nanoparticle-based biosensor platform. J Med Virol 95(2):28479. https:\/\/doi.org\/10.1002\/jmv.28479","journal-title":"J Med Virol"},{"issue":"6","key":"3385_CR112","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani A et al (2024) A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187(6):1363-1373.e12. https:\/\/doi.org\/10.1016\/j.cell.2024.01.017","journal-title":"Cell"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03385-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T04:47:15Z","timestamp":1739422035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03385-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3385"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03385-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}